Latest market price
12.20
-0.24-1.93%
TA
Loading chart...
Snapshot
| Index | — | P/E | 10.91 | EPS (ttm) | 1.14 | Insider Own | 0.01% | Shs Outstand | 2.22B | Perf Week | 1.50% |
| Market Cap | 27.59B | Forward P/E | 9.53 | EPS next Y | 1.31 | Insider Trans | -77.96% | Shs Float | 742.56M | Perf Month | 2.61% |
| Enterprise Value | 31.58B | PEG | 0.16 | EPS next Q | 0.04 | Short Float | 5.68% | Perf Quarter | -10.95% | ||
| Income | 1.19B | P/S | 0.39 | EPS this Y | -64.89% | Short Ratio | 7.41 | Perf Half Y | -24.88% | ||
| Sales | 71.42B | P/B | 15.74 | EPS next Y | 90.87% | ROA | 13.98% | Short Interest | 42.15M | Perf YTD | -15.40% |
| Book/sh | 0.79 | P/C | 41.12 | EPS next 5Y | 68.61% | ROE | 17.67% | 52W High | 18.65 -34.58% | Perf Year | -7.65% |
| Cash/sh | 0.30 | P/FCF | 76.65 | EPS past 3/5Y | 10.91% 40.87% | ROIC | 36.64% | 52W Low | 10.61 14.99% | Perf 3Y | — |
| Dividend Est. | 2.00 (16.39%) | EV/EBITDA | 5.58 | Sales past 3/5Y | 4.47% 9.96% | Gross Margin | 11.86% | Volatility | 2.56% 2.85% | Perf 5Y | — |
| Dividend TTM | 1.00 (8.20%) | EV/Sales | 0.44 | EPS Y/Y TTM | 18.78% | Oper. Margin | 3.84% | ATR (14) | 0.41 | Perf 10Y | — |
| Dividend Ex-Date | May 18, 2026 | Quick Ratio | 0.93 | Sales Y/Y TTM | -10.86% | Profit Margin | 1.68% | RSI (14) | 46.61 | Recom | 2.00 |
| Dividend Gr. 3/5Y | 10.68% 42.10% | Current Ratio | 1.53 | EPS Q/Q | -62.26% | SMA20 | -2.77% | Beta | 0.19 | Target Price | 17.50 |
| Payout | 12.20% | Debt/Eq | 2.66 | Sales Q/Q | -77.42% | SMA50 | -2.13% | Rel Volume | 0.81 | Prev Close | 12.44 |
| Employees | 283,000 | LT Debt/Eq | 2.51 | Earnings | Nov 09 | SMA200 | -13.34% | Avg Volume | 5.95M | Price | 12.20 |
| IPO Date | Jun 13, 2025 | Option/Short | Yes / Yes | EPS/Sales Surpr. | — | Net Debt/EBITDA | 0.70 | Volume | 4,839,116 | Change | -1.93% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-24-26 | Reiterated | UBS | Buy | $17 → $18 |
| Aug-17-26 | Reiterated | Stephens & Co. | Overweight | $17 |
| Jul-28-26 | Upgrade | JP Morgan | Neutral → Overweight | |
| Jul-16-26 | Reiterated | Barclays | Overweight | $23 → $20 |
| May-19-26 | Reiterated | UBS | $19 → $17 | |
| Mar-27-26 | Reiterated | Barclays | Overweight | $23 |
| Feb-05-26 | Initiated | UBS | Buy | $20 |
| Dec-11-25 | Reiterated | Banco Santander | $17 | |
| Nov-26-25 | Reiterated | Goldman Sachs | $21 → $19 | |
| Oct-28-25 | Reiterated | Mizuho Securities | $22 → $20 |
Latest News· Times ET
Nov-02-26
Nov-02-2611:01AM
Oct-27-26
Oct-27-2608:52AM
Oct-23-26
03:39AM
Jbs N.V. $JBS Stake Trimmed by Assenagon Asset Management S.A.defenseworld.net
Oct-22-26
Oct-13-26
Oct-13-2604:30PM
03:13AM
Oct-10-26
Oct-10-2608:35AM
Oct-08-26
Oct-05-26
Oct-05-2606:31AM
Oct-03-26
Sep-23-26
Sep-23-2611:31AM
Sep-21-26
Sep-16-26
Company
JBS NV is a food company that engages in the sale of beef, pork, lamb meat and poultry products. It offers its products to supermarkets, club stores, other retail distributors, and foodservice companies. The company was founded on October 9, 2019 and is headquartered in Amstelveen, the Netherlands.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 71,417 | 84,271 | 77,144 | 72,814 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 62,964 | 73,481 | 65,530 | 64,879 | — | — | — | — | — | |
| Gross Profit | 8,454 | 10,790 | 11,614 | 7,935 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 5,672 | 6,757 | 6,844 | 6,800 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 53 | -14 | 374 | 74 | — | — | — | — | — | |
| Operating Income | 2,729 | 4,047 | 4,397 | 1,061 | — | — | — | — | — | |
| Interest Expense | 1,123 | 1,642 | 305 | 347 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -170 | 171 | -1,350 | -994 | — | — | — | — | — | |
| Net Income Before Taxes | 1,437 | 2,576 | 2,742 | -280 | — | — | — | — | — | |
| Income Taxes | 147 | 389 | 762 | -134 | — | — | — | — | — | |
| Consolidated Net Income | 1,186 | 1,985 | 1,779 | -212 | — | — | — | — | — | |
| Net Income From Continuing Operations | 1,290 | 2,187 | 1,980 | -146 | — | — | — | — | — | |
| Net Income | 1,186 | 1,985 | 1,779 | -212 | — | — | — | — | — | |
| EPS (Recurring) | 0.70 | 1.86 | 0.15 | -0.10 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.70 | 1.86 | 0.15 | -0.10 | — | — | — | — | — | |
| EPS (Diluted) | 1.14 | 1.86 | 0.15 | -0.10 | — | — | — | — | — | |
| EBITDA | 5,662 | 6,477 | 6,965 | 3,270 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 10.70 | 7.74 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.18 | 0.18 | — | — | — | — | — | — | — | |
| Gross Margin | 11.84 | 12.80 | 15.05 | 10.90 | — | — | — | — | — | |
| Operating Margin | 3.82 | 4.80 | 5.70 | 1.46 | — | — | — | — | — | |
| Net Margin | 1.66 | 2.36 | 2.31 | -0.29 | — | — | — | — | — | |
| Shares Outstanding | 1,071 | 1,069 | 2,218 | 2,218 | — | — | — | — | — | |
| Market Capitalization | 13,066 | 15,415 | — | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cavalcanti Guilherme Perboyre | Global CFO and IRO | Aug 24 '26 | Sale | 13.85 | 183,501 | 2,541,489 | 0 | Aug 25 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.